Focus on the Top Line – The Bottom Line Will Follow


Maybe the secret of stock market winners isn't in chasing net income, but in focusing on revenue growth? Steve Jobs' 1997 mantra led Apple to success — and is a principle every investor must understand to find the next compounder. Our original analysis for The Market by NZZ — plus the extended investor's view.
This statement by Steve Jobs has burned itself into my memory.
It underlines a simple but powerful truth: revenue is the engine that drives everything else.
Few moments in business history illustrate this like Apple in 1997. Back then, the company stood at the edge of bankruptcy when Steve Jobs returned. In an interview, he explained his turnaround strategy with this remarkable insight:
«Someone taught me a very valuable lesson long ago: if you do the right things on the top line of the company, the bottom line will follow. [...] If you have the right strategy, the right people, and the right corporate culture, you'll make the right products. You'll do the right marketing. You'll do the right things logistically, in production and distribution. And if you do all these things right, the bottom line will follow.»
— Steve Jobs, 1997
Steve Jobs' 1997 mantra led Apple to success. It's a principle every investor must understand to find the next compounder. Add to it one of the most effective financial levers tied to this concept, a metric that can drive stock prices upward over the long run:
Margin improvement.
→ Read the full article on The Market by NZZ
Chart 1: Upward trend in S&P 500 profit margins

Source: NZZ The Market
Steve Jobs' statement is intellectually undeniable — and has been publicly available for 28 years. Still, the majority of retail investors are fixated on quarterly earnings, EPS surprises, and short-term margin movements. This question doesn't fit into an NZZ column with the necessary depth — but it's the key to understanding why so few investors actually find compounders: the market rewards the bottom line short-term, the top line long-term — and most investors operate in the wrong time zone.
Three structural reasons why investors systematically look at the wrong thing:
Quarterly EPS swings are noise. Margin trajectories over 3-5 years are signal. Top-line growth over 5-10 years is substance. Investors reacting to noise trade constantly — and miss substance. Disciplined investors react to substance, ignore the signal-noise spectrum, and stick to top-line trends as primary indicator. This discipline isn't smarter than quarterly-report reaction — it's just structurally superior because it aligns with the mathematical reality of long-term value creation.
Steve Jobs' statement isn't "revenue is everything, profit doesn't matter". It's a model for the order of attention. Get the top line right, then the bottom line follows. But the most effective compounders combine both levers simultaneously: organic top-line growth plus margin expansion. When both work together, this becomes mathematically the strongest stock-price driver that exists.
Over 10 years: earnings tripling instead of doubling. Over 20 years: factor 14× instead of 6×.
The leverage of margin expansion on the bottom line is non-linear. When a business has 10% top-line growth and simultaneously improves operating margin from 15% to 20% over 5 years, the bottom line in this period grows roughly twice as fast as the top line. Over 20 years this effect compounds into returns unattainable with pure growth or pure margin optimisation alone.
(1) Operating leverage — when fixed costs stay constant and top line grows, margins expand automatically. This is the purest mathematical lever and works in almost every scalable business.
(2) Pricing power — brands, moats, or switching costs allow price increases above inflation. Here margin expansion is a consequence of competitive position, not efficiency.
(3) Mix shift — when higher-margin product lines grow faster than lower-margin ones, the business mix shifts and overall margin expands without anything having to be improved on individual products.
Apple is the textbook example for top line × margin expansion. From 1997 to 2024, the top line grew from around 7 bn to 391 bn USD — factor 56. In the same period operating margin rose from negative (loss-making) to consistently above 30%. The bottom line in the same period grew from deeply negative to 100+ bn USD annually — factor undeterminable, because loss to profit can't be expressed in a multiplier. The stock compounded over the entire period at around 28% per year — one of the best stock performances in history. Exactly that's the mechanic Jobs' mantra describes.
The top-line lens is one of the most pragmatic selection tools in quality investing. It helps with the most important step: distinguishing real compounders from apparent ones. Three diagnostic questions every one of your top positions must pass:
| Question | What to check |
|---|---|
| 1. How high is organic top-line growth over the last 5 years? | Acquisition-adjusted, FX-adjusted. Real organic growth below 5% is stagnation signal. 7-15% is the compounder zone (cf. Trees Don't Grow to the Sky). |
| 2. How have operating margins developed over 5 years? | Stable or rising is good. Creeping decline is early signal of structural weakness. Strongly fluctuating is signal of lacking pricing power. |
| 3. Which of the three margin expansion sources apply? | Operating leverage, pricing power, or mix shift — ideally several simultaneously. If none applies, bottom-line growth is just top-line growth without the compounding lever. |
Anyone who can answer all three questions positively has a real compounder in front of them. Such businesses are rare — perhaps 50-100 worldwide. But the few that exist deliver structurally the best long-term shareholder returns, often 15-25% annually over very long periods.
| Investor profile | Typical top-line discipline | What to check |
|---|---|---|
| "I follow the MSCI World" | Mix with partly weak top-line businesses | Conscious selection on 7-15% top-line growth with margin expansion |
| "I focus on hypergrowth" | Top-line often >25%, but margins often negative | Check margin path realistically — when does the business become profitable? |
| "I buy dividend stocks" | Top-line often <5%, margins stable | Check compounding gap — is the top-line engine missing? |
| "I focus on quality compounders" | Top-line 7-15%, margin expansion visible | Hold discipline, track top-line trajectory every quarter |
Compounders show their strengths over very long periods. But for the question of entry, build-up, or holding in the next 18 months, plausible paths help:
Quality compounders with established moats use AI as efficiency lever — operating margins expand more strongly than historically. The combination of stable top-line growth and accelerated margin expansion delivers above-average bottom-line growth rates. Stock prices reflect this with significant excess return over broad indices.
Quality compounders deliver their typical returns — operating growth 9-13% plus 0.3-0.5 percentage points margin expansion annually. Bottom line grows correspondingly 12-16% annually. Over 20 years this compounds into 15-20% annual stock returns with significantly smaller drawdowns than broad indices. Our base case.
A combination of AI disruption (cf. Kodak Moment companion) and geopolitical shifts (tariffs, supply chains) presses margins of many quality compounders. Top line stays stable, but margin expansion stalls or reverses. Bottom-line growth slows to top-line level. Stock prices reflect this with multiple resets — good for buyers, painful for holders with high valuations.
An honest top-line analysis of your portfolio takes 30 minutes and is one of the most valuable exercises for any serious investor. Four concrete checks:
1. Top-line inventory of your top 10 positions. Look at organic top-line growth rates over the last 5 years. How many of your largest positions grow organically in the 7-15% zone? For most investors this reveals: 30-50% of the portfolio grows top-line either <5% (stagnation) or >25% (hypergrowth with expectation risks).
2. Margin expansion check. How many of your positions have actually improved their operating margin over the last 5 years? Without margin expansion, bottom-line growth is just an echo of top-line — the compounding lever is missing. Creeping margin erosion is the clearest early signal of structural weakness.
3. Manipulation test. For which of your positions does bottom-line growth come from real operating leverage — and for which from share buybacks, cost-cutting, or balance sheet engineering? That's a discipline exercise many investors avoid because the results are often uncomfortable.
4. 10-year projection. When you project your top 10 positions 10 years forward — top line × margin expansion = projected bottom line — for which is the compounding mechanic real, and for which do you live on hope? This exercise is the toughest reality check for any portfolio.
They don't panic-sell their stagnation-prone positions — that would be reaction instead of strategy. They systematically check their portfolio for the top line × margin expansion mechanic, identify real compounders with both levers, and build up gradually. Over 18-24 months the allocation shifts gradually to businesses that structurally live the mathematical compounding mechanic. That's not spectacular, but it's exactly what Steve Jobs described in 1997 as a strategy for Apple — and what serves any serious investor today as selection lens just as well.
No, Apple is referenced here exclusively as a historical textbook example for the top line × margin expansion mechanic. Whether to buy the stock today is a separate question depending on current valuation, growth trajectory, and AI disruption risks. What's transferable is the selection logic — you can apply this to any stock on your watchlist, regardless of whether you hold Apple yourself or not.
That's the classic hypergrowth constellation. It's not bad per se — but it shifts the risk from "performance of the next 12 months" to "will this business ever become profitable?". Disciplined investors ask: is there a clear path to profitability, and when does the business reach it? Without clear answer, the business is speculation, not investment.
Most businesses report "organic growth" as separate metric in quarterly reports. If not, the difference between total growth and acquisition contribution (often mentioned in the appendix) can be calculated yourself. Acquisition-driven growth isn't necessarily bad, but structurally different: it costs capital, often integrates poorly, and is mostly not scalable. Real compounders grow primarily organically.
Yes — the top line × margin expansion mechanic is a central lens in arvy's selection process. Concrete current positions are documented transparently in the arvy Q1 2026 Quarterly Report.
Further reading — the thematic anchors of this analysis
Steve Jobs' mantra is 28 years old and mathematically unchanged in relevance. It doesn't describe a fad of investing, but the fundamental order of value creation in businesses. Top line is the strategy — it comes from the right positioning, the right culture, the right people, the right products. Bottom line is the mathematical consequence of it, when the top line stands right and operating leverage, pricing power, or mix shift expand the margins.
Investors who understand and discipline this look differently at every stock. They don't ask "what will the quarterly earnings be", but "how does the 5-year top-line trend look". They don't react to EPS beats, but to margin trajectories. They build portfolios with real compounders instead of apparent ones. And over 15-20 years this discipline delivers returns mathematically unattainable with quarterly-report reactions. Steve Jobs described it for Apple in 1997. It applies today just as well to every serious investor.
Original written by Thierry Borgeat, Co-Founder of arvy, for The Market by NZZ. The extended arvy companion piece reviewed by Patrick Rissi, CFA and Florian Jauch, CFA. Data sources: NZZ The Market, own analyses, Steve Jobs interview 1997 (public), Apple Investor Relations historical data. Last updated: April 2026.
Disclaimer: This article is for general educational purposes and does not constitute personal investment advice. The security designations mentioned are illustrative and not buy or sell recommendations. Past performance is no guarantee of future results. Scenarios are assessments, not forecasts. arvy is a FINMA-supervised asset manager with a CISA licence (Art. 24). Imprint & Legal Notice.